Incyte (NASDAQ:INCY) Rating Reiterated by Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their neutral rating on shares of Incyte (NASDAQ:INCY – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. Several other brokerages have also issued reports on INCY. JPMorgan Chase & Co. lifted their price objective on shares of Incyte from $59.00 to $61.00 and gave the company […]

Leave a Reply

Your email address will not be published.

Previous post OPKO Health’s (OPK) “Buy” Rating Reiterated at HC Wainwright
Next post LKQ (NASDAQ:LKQ) Downgraded to Hold at StockNews.com